Quarterly Risperidone (QUAR)

risperidone · Rovi Pharmaceuticals Laboratories

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quarterly Risperidone (QUAR), covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia [Phase 1]

See pricing